Human and rat cutaneous mast cells: involvement of a G protein in the response to peptidergic stimuli
- PMID: 7536161
- DOI: 10.1016/0014-2999(94)00628-k
Human and rat cutaneous mast cells: involvement of a G protein in the response to peptidergic stimuli
Abstract
Recent evidence suggests that peptides induce the release of mediators from rat peritoneal mast cell by means of a receptor-independent mechanism, possibly involving an interaction with sialic acid residues at the cell surface followed by the activation of a guanine nucleotide binding protein (G protein). We have now examined the potential involvement of sialic acid residues and of G protein stimulation in the activation of both human and rat cutaneous mast cells by neuropeptide Y, its C-terminal fragments and the wasp venom peptide, mastoparan. Neuropeptide Y-(18-36) was the most effective histamine releaser of the fragments tested, the order of potency being neuropeptide Y-(18-36) > neuropeptide Y-(22-36) > neuropeptide Y-(1-36). This order of potency suggests that the effects of the peptides are not mediated through classical NPY receptors. The hydrolysis of sialic acid residues by neuraminidase and the inhibition of G proteins by benzalkonium chloride or pertussis toxin significantly inhibited the secretory response of cutaneous mast cells to neuropeptide Y-(18-36) and mastoparan. These results demonstrate that the peptidergic pathway described for the activation of peritoneal rat mast cells is also involved in the response of cutaneous human and rat mast cells to peptides.
Similar articles
-
Role of positive charges of neuropeptide Y fragments in mast cell activation.Agents Actions. 1994 Jun;41 Spec No:C41-2. doi: 10.1007/BF02007758. Agents Actions. 1994. PMID: 7526655
-
Neuropeptide Y and truncated neuropeptide Y analogs evoke histamine release from rat peritoneal mast cells. A direct effect on G proteins?Eur J Pharmacol. 1994 Jun 2;258(1-2):163-6. doi: 10.1016/0014-2999(94)90071-x. Eur J Pharmacol. 1994. PMID: 7523149
-
Role of G-proteins in peptidergic activation of both human and rat cutaneous mast cells.Inflamm Res. 1995 Apr;44 Suppl 1:S26-7. doi: 10.1007/BF01674379. Inflamm Res. 1995. PMID: 8520984 No abstract available.
-
Peptidergic pathway in human skin and rat peritoneal mast cell activation.Immunopharmacology. 1994 Jan-Feb;27(1):1-11. doi: 10.1016/0162-3109(94)90002-7. Immunopharmacology. 1994. PMID: 7515863 Review.
-
G protein activation: a receptor-independent mode of action for cationic amphiphilic neuropeptides and venom peptides.Trends Pharmacol Sci. 1990 Sep;11(9):358-62. doi: 10.1016/0165-6147(90)90179-c. Trends Pharmacol Sci. 1990. PMID: 2122563 Review.
Cited by
-
Mechanism of peptide-induced mast cell degranulation. Translocation and patch-clamp studies.J Gen Physiol. 1998 Nov;112(5):577-91. doi: 10.1085/jgp.112.5.577. J Gen Physiol. 1998. PMID: 9806967 Free PMC article.
-
Recent developments in low molecular weight complement inhibitors.Mol Immunol. 2009 Dec;47(2-3):185-95. doi: 10.1016/j.molimm.2009.08.032. Epub 2009 Oct 2. Mol Immunol. 2009. PMID: 19800693 Free PMC article. Review.
-
Structure activity studies of mast cell activation and hypotension induced by neuropeptide Y (NPY), centrally truncated and C-terminal NPY analogues.Br J Pharmacol. 1996 Jan;117(2):325-32. doi: 10.1111/j.1476-5381.1996.tb15194.x. Br J Pharmacol. 1996. PMID: 8789386 Free PMC article.
-
Overexpression of FcεRI on Bone Marrow Mast Cells, but Not MRGPRX2, in Clonal Mast Cell Disorders With Wasp Venom Anaphylaxis.Front Immunol. 2022 Feb 25;13:835618. doi: 10.3389/fimmu.2022.835618. eCollection 2022. Front Immunol. 2022. PMID: 35281031 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous